Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Luger

Showing results (231-240 of 311) with videos related to

Pageof 32
Sort By:
Bone Marrow Transplantation|June 14, 2006
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantationJ Svoboda, C Andreadis, R Elstrom, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With MyelomaThomas M Paul, Stephen V Liu, Elise A Chong, et al.
Bone Marrow Transplantation|May 26, 2018
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, Noelle V Frey, Elizabeth O Hexner, et al.
Blood|May 24, 2003
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantationGinna G Laport, Bruce L Levine, Edward A Stadtmauer, et al.
Blood Advances|October 21, 2022
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 studyIbrahim Aldoss, Jun Yin, Anna Wall, et al.
Cancer Biology & Therapy|January 6, 2007
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexaroteneDonald E Tsai, Selina M Luger, Allison Kemner, et al.
Haematologica|November 24, 2018
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Cancer|May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysisJames M Foran, Zhuoxin Sun, Catherine Lai, et al.
Leukemia|December 10, 2016
High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALLS K Tasian, C Hurtz, G B Wertheim, et al.
American Journal of Hematology|December 15, 2015
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)Clive S Zent, Xin Victoria Wang, Rhett P Ketterling, et al.
Pageof 32

Showing results (231-240 of 311) with videos related to

Sort By:
Pageof 32
Bone Marrow Transplantation|June 14, 2006
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantationJ Svoboda, C Andreadis, R Elstrom, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With MyelomaThomas M Paul, Stephen V Liu, Elise A Chong, et al.
Bone Marrow Transplantation|May 26, 2018
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, Noelle V Frey, Elizabeth O Hexner, et al.
Blood|May 24, 2003
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantationGinna G Laport, Bruce L Levine, Edward A Stadtmauer, et al.
Blood Advances|October 21, 2022
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 studyIbrahim Aldoss, Jun Yin, Anna Wall, et al.
Cancer Biology & Therapy|January 6, 2007
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexaroteneDonald E Tsai, Selina M Luger, Allison Kemner, et al.
Haematologica|November 24, 2018
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Cancer|May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysisJames M Foran, Zhuoxin Sun, Catherine Lai, et al.
Leukemia|December 10, 2016
High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALLS K Tasian, C Hurtz, G B Wertheim, et al.
American Journal of Hematology|December 15, 2015
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)Clive S Zent, Xin Victoria Wang, Rhett P Ketterling, et al.
Pageof 32